ORGANIZATION
Pharma Leader Nakayama Hails Tax Plan, Says His New Year Remarks Misleading
Pharma leader Joji Nakayama clarified himself on January 14 about his New Year remarks on the government’s tax plan, saying that he believes drug makers will be able to reap benefits from a revamped R&D tax credit system if it…
To read the full story
Related Article
- Pharma Biz Leader Airs Concern over Effective Tax Hikes
January 8, 2015
ORGANIZATION
- JPMA Exec Renews Call for Simpler Drug Pricing System
December 19, 2025
- JGA to Create “Stable Supply Network” Membership to Expand Ramp-Up Scheme
December 18, 2025
- Pharma Groups Reiterate “No” to Broader CEA Use, Huge-Seller and Spillover Rules: Joint Statement
December 17, 2025
- Japan Medical Societies Recommend RSV Vaccination for Older Adults
December 15, 2025
- Labor Union Group Submits Request, Urges Drug Pricing Overhaul amid Inflation
December 3, 2025
Let’s be real: even with the best intentions, AI systems can reflect our own unconscious biases. As Daniel Kahneman and Amos Tversky famously demonstrated in their groundbreaking work on Prospect Theory, humans are prone to cognitive biases that influence our…





